RareCyte

RareCyte is a private, revenue-generating diagnostics company providing cutting-edge tools and services in the high-growth fields of spatial biology and liquid biopsy. Its core platforms, Orion and CyteFinder, deliver high-plex tissue imaging and ultra-sensitive rare cell detection, respectively, catering to translational research and clinical trial support. With an experienced leadership team and a focus on precision medicine, the company aims to translate spatial insights into clinical impact. RareCyte operates a service-based business model through its CLIA lab and CRO network, positioning it at the intersection of research tools and clinical diagnostics.

Orion HT: High-plex (20-channel) multiplex immunofluorescence imaging system for spatial biology on tissue samples. CyteFinder: Automated imaging platform for rare cell detection, characterization, and retrieval from blood for liquid biopsy applications.

In spatial biology, competes directly with Akoya Biosciences, NanoString Technologies, and Visiopharm. In liquid biopsy (CTC detection), faces competition from companies like Menarini Silicon Biosystems and Fluxion Biosciences, as well as the broader ctDNA market. Its hybrid instrument/service model competes with large CROs and core labs.